| Haemophilus influenzae |
Haemophilus influenzae, formerly called Pfeiffer's bacillus, is a non-motile Gram-negative coccobacillus first described in 1892 by Dr. Robert Pfeiffer during the influenza pandemic. It is generally aerobic, but can grow as a facultative anaerobe. Haemophilus influenzae was mistakenly considered to be the cause of the common flu until 1933, when the viral etiology of the flu became apparent. Still, Haemophilus influenzae is responsible for a wide range of clinical diseases. ...
Ãâó: en.wikipedia.org/wiki/Haemophilus_influenzae
|
|---|---|
| Haemophilus influenzae type b |
Haemophilus influenzae, formerly called Pfeiffer's bacillus, is a non-motile Gram-negative coccobacillus first described in 1892 by Dr. Robert Pfeiffer during the influenza pandemic. It is generally aerobic, but can grow as a facultative anaerobe. Haemophilus influenzae was mistakenly considered to be the cause of the common flu until 1933, when the viral etiology of the flu became apparent. Still, Haemophilus influenzae is responsible for a wide range of clinical diseases. ...
Ãâó: en.wikipedia.org/wiki/Haemophilus_influenzae_type_...
|
| Haemophilus |
influenzae (Also called H. influenzae) - Represents a group of bacteria that may cause different types of infections in infants and children. H. influenzae most commonly causes ear, eye, or sinus infections, and pneumonia.
Ãâó: uuhsc.utah.edu/healthinfo/pediatric/pediatrics/glo...
|
| Haemophilus influenzae |
Represents a group of bacteria that may cause different types of infections in infants and children. H. influenzae most commonly causes ear, eye, or sinus infections, and pneumonia.
Ãâó: content.jeffersonhospital.org/content.asp
|
| Haemophilus b conjugate v. |
a preparation of Haemophilus influenzae type b capsular polysaccharide covalently bound to diphtheria toxoid or to a specific diphtheria protein, meningococcal protein, or tetanus protein; it stimulates both B and T lymphocyte responses and is much more immunogenic than the polysaccharide vaccine. Administered intramuscularly as a routine immunizing agent in children between the ages of 2 months and 5 years.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
|